Amgen International Explores Expansion Plans

DUBAI — Dubai Biotech-nology and Research Park, or DuBiotech, a major life sciences hub in the Middle East and a member of TECOM Investments, announced Amgen International, the world’s largest biotechnology company with an estimated market capitalisation of $65 billion, discussed expansion plans during a meeting of senior management members.

By (Staff Report)

  • Follow us on
  • google-news
  • whatsapp
  • telegram

Published: Sun 23 Aug 2009, 11:05 PM

Last updated: Sun 5 Apr 2015, 9:33 PM

Amgen was one of the first biotech companies to establish operations in the Middle East.Founded in 2006, Amgen’s local organisation has since launched activities in several countries in the Middle East, as well as Turkey and South Africa. The headquarters for Amgen’s Middle East, Africa and Turkey, or MEAT, operations is located atDuBiotech.

The meeting was attended by Rolf Hoffman, Senior Vice President-Commercial Operations, Amgen International; Dr Amina Al Rustamani, CEO of TECOM Business Parks; Dr Marco Baccanti, Executive Director of DuBiotech, and Ashraf Allam, the Regional Managing Director of Amgen headquarters for Middle East, Africa and Turkey.

Currently, DuBiotech hosts some of the world’s top pharmaceutical and biotechnology companies and has firmly established itself as a globally recognised centre for the life science industries.

More news from